鞍重股份(002667.SZ):擬收購江西興鋰科技不低於51%股權
格隆匯6月16日丨鞍重股份(002667.SZ)公佈,公司於2021年6月16日與江西省宜豐縣同安礦產品開發有限公司(“江西同安”)簽訂《現金購買資產意向協議》。公司擬以自有資金收購江西同安持有的江西興鋰科技有限公司(“標的公司”)不低於51%股權。上述交易完成後,公司將持有標的公司不低於51%的股權。
公司此次收購是為了開拓新的業務板塊,依託原有的礦山機械主營業務,向上游選礦廠延伸發展。此次交易符合公司長遠規劃。公司此次收購股權的資金為自有資金,交易完成後,江西興鋰科技有限公司將成為公司的控股子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.